Sana Biotechnology, Inc. (SANA)
↓ Download CSVKey ratios (FY2025)
-151.8%
Return on equity
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|
| Operating Income | -$250.32M | -$272.72M | -$293.14M | -$272.56M | -$356.91M | -$286.15M | -$141.15M | — |
| Net Income | -$244.17M | -$266.76M | -$283.25M | -$269.48M | -$355.93M | -$285.31M | -$130.78M | — |
| EPS (Diluted) | $-0.96 | $-1.16 | $-1.46 | $-1.43 | $-2.14 | $-21.92 | — | — |
| Total Assets | $416.89M | $501.02M | $565.30M | $822.72M | $1.13B | $730.30M | — | — |
| Total Liabilities | $256.01M | $250.52M | $277.79M | $323.40M | $400.90M | $298.58M | — | — |
| Shareholders' Equity | $160.88M | $250.50M | $287.51M | $499.31M | $728.50M | -$421.18M | -$142.54M | -$13.19M |
| Cash & Equivalents | $71.87M | $127.57M | $133.52M | $176.76M | $253.03M | $124.81M | — | — |
| Operating Cash Flow | -$143.83M | -$223.15M | -$253.58M | -$290.05M | -$251.05M | -$137.98M | -$85.52M | — |
| Capital Expenditures | $938.0K | $33.43M | $20.03M | $20.88M | $29.86M | $23.87M | $26.12M | — |
| Shares Outstanding | 266.73M | 223.92M | 197.86M | 191.02M | 184.93M | 16.17M | — | — |